Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

NCT07495098 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT07495098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07495098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer
Lead sponsor
University of Vermont
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2031
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc), lung cancer metastatic